Michael Schaffzin | Stern Investor Relations |
Derek Chalmers | Co-Founder, President, CEO & Director |
Mani Mohindru | CFO & Chief Strategy Officer |
Nicholas Rubino | Stifel, Nicolaus & Company |
David Amsellem | Piper Jaffray Companies |
Laurence Carr | Needham & Company |
Oren Livnat | H.C. Wainwright & Co. |
Kenneth Trbovich | Janney Montgomery Scott LLC |
Good afternoon, and welcome to Cara Therapeutics' Second Quarter 2018 Financial Results Conference Call. [Operator Instructions]. Please be advised that the call is being recorded at Cara's request. I will now turn the call over to the Cara team. Please proceed.